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A Review of Stability Issues Associated with Vitamins 
in Parenteral Nutrition 
Abstract 
Background & aims: There has been a move to increased emphasis on 
delivering parenteral nutrition to patients at home, which may improve patient 
care and reduce costs. However, safe provision of home, and indeed any, 
parenteral nutrition necessitates consideration of the physical and chemical 
stability of the parenteral nutrition and its components.  
Methods: Medline and Embase were used to search for all English-language 
publications on vitamin stability. Identified publications were then analysed 
and summarised in the following review. 
Results: Vitamins are one of the least stable components in PN and there are 
three main ways in which they have been shown to degrade: 
photodegradation, oxidation and through storage material interaction. 
Previous research on vitamins has demonstrated that significant losses can 
occur in the bag, which could have clinical consequences, particularly for 
long-term users of parenteral nutrition. These losses are most dramatic for 
vitamin C, which is rapidly degraded by oxygen, and vitamin A, which is 
rapidly degraded in the presence of sunlight.  
Conclusions: There are a number of stability issues associated with vitamins 
in parenteral nutrition and further investigation is needed to assure their 
stability and compatibility with other parenteral nutrition constituents. 
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Introduction 
 
Historically, Parenteral Nutrition (PN) was prepared at ward level in a multi-
bottle dose system1. This method was labour intensive and was readily 
susceptible to contamination. This called for the introduction of an all-in-one 
(AIO) bag, which would decrease the incidence of infection and be a 
convenient and cost-effective alternative to the multi-bottle system previously 
employed1–3. The use of an AIO bag meant that all macronutrients, vitamins, 
trace elements and electrolytes were introduced to the same bag prior to 
administration, leading to a number of formulation and stability issues. 
 
At present, there is a drive within the NHS to treat patients at home in an 
attempt to significantly reduce costs and improve clinical outcomes4,5. An 
increased emphasis on delivering treatments at home has stimulated 
researchers to investigate the sources of instability within PN admixtures, 
thereby validating shelf lives and allowing more convenient administration at 
home. 
 
One aspect of PN that has not been fully investigated is the addition of 
vitamins. Vitamins are highly reactive and their addition to PN admixtures can 
cause a number of pharmaceutical issues. Reactions involving vitamins are 
dependent on: relative concentrations of reactants, pH, temperature, time, 
container material and the presence of any other catalytically active 
components6. The reactive nature of vitamins mean they should be added 
shortly before administration to ensure that the integrity of the admixture is 
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maintained7. There are three main types of vitamin instability seen in PN: 
photodegradation, oxidation and interactions with storage material8. In every 
PN admixture administered a patient should receive a days supply of vitamins 
and trace elements9. Ensuring that patients are administered with sufficient 
amounts of vitamins is essential for normal bodily function and to prevent the 
manifestation of clinical symptoms of deficiency. Water-soluble vitamins in 
particular require regular dosing as they are not stored in significant amounts 
in the body, with the exception of vitamin B12. Ensuring adequate dosing of 
fat-soluble vitamins is also important especially in patient groups such as 
infants, who only have small quantities of fat-soluble vitamins stored10.  
 
Stability problems encountered with PN admixtures can occur in containers or 
administration sets. This is especially problematic for premature infants who 
receive their PN at slow infusion rates10. These stability issues can prevent 
patients from getting their intended doses or may harm the patient either 
through generation of potentially harmful by-products or interfere with the 
physical stability of the admixture8. A better grasp of how vitamins interact 
with the environment they are stored in and other PN components will ensure 
the safe use of them in the future.  
 
The following review examines the current information available on the 
stability issues associated with vitamins. 
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Fat Soluble Vitamins 
Vitamin A 
 
Vitamin A, or retinol, is the most light-sensitive micronutrient found in PN 
admixtures. When subjected to light in unprotected bags or administration 
sets, it undergoes extensive photodegradation11–13. The mechanism of this 
reaction is still not fully understood, but it is known that the wavelength and 
the intensity of the light interacting with the vitamin determines the rate of the 
photochemical reaction12. A study by Allwood and Plane14 showed that retinol 
is more susceptible to photodegradation when exposed to wavelengths of less 
than 400 nm, with maximum degradation occurring between 330-350 nm. 
Such wavelengths are more commonly found in natural daylight, with artificial 
light emitting smaller amounts of wavelengths in the UV range12. 
Nevertheless, a recent study by Ferguson et al.15 has found significant 
degradation (in excess of 10%) when retinol is exposed to artificial lighting 
that would be commonly found in hospitals and homes: cool white light and 
warm white light.  
The inclusion of lipid in all-in-one (AIO) admixtures has resulted in the opacity 
of the admixture being increased significantly. There have been conflicting 
reports13,16, but the addition of lipid does not seem to provide sufficient 
protection for light sensitive vitamins such as retinol12. Therefore, to assure 
retinol photostability in PN light-protective covers should be used. 
Since these studies on retinol degradation were performed there has been a 
change in lighting preference, with a number of aseptic units using energy-
saving light bulbs. Similar changes have also occurred in homes in an attempt 
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to reduce costs. The impact of this change in lighting on retinol degradation 
has not yet been investigated fully. Until more is known about its influence on 
the degradation of retinol the use of light protection is essential17. 
 
Besides photodegradation, sorption of retinol may occur with bags and 
administration set tubing, further reducing the amount of vitamin being 
administered to the patient8. This problem has been much reduced through 
the use of the less reactive palmitate ester, rather than the acetate ester10. 
The introduction of tubing containing polyolefine, which is free of PVC, 
plasticisers, adhesives or latex, has further reduced the absorption of vitamin 
A18.  
 
Another source of degradation of vitamins are peroxides generated by lipid 
emulsions. Lipid emulsions containing polyunsaturated fatty acids (PUFAs) 
are at an increased risk of peroxidation19. Vitamin E acts as a major 
scavenger for free radicals and prevents lipid peroxyl radicals from reacting 
with fatty acid side chains20. Nevertheless, peroxiodation still occurs to some 
degree. Guidetti et al.21 have studied the impact of different lipid emulsion 
compositions on vitamin degradation via peroxidation. Following 24 hours of 
light protected storage at room temperature Guidetti et al. found that retinol 
recovery was significantly increased in soybean-medium chain triacylglycerol 
oil-based emulsions when compared to soybean oil-based emulsions and 
olive/soybean oil-based emulsions. Further investigation is required to 
understand the relationship between the composition of lipid emulsions and 
the degradation of vitamins. 
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Vitamin D 
 
As described by Allwood and Kearney8, there are very limited stability data 
available for vitamin D in PN. The only study on this vitamin has shown that 
following a 24-hour infusion period, 68% of the vitamin D concentration was 
recovered. Comparison of sample concentrations at various sites within the 
infusion set-up suggested that vitamin D may bind to plastic found in bags and 
administration sets22.  
 
There has been a lot of recent interest in vitamin D, especially with the re-
emergence of rickets in some urban areas. Consequently, there has been a 
call to increase its recommended daily allowance in countries such as the 
United States of America and Canada23. This may, in turn, lead to an increase 
in the recommended amount of vitamin D being given to PN patients. 
 
Vitamin E 
 
Vitamin E is degraded by oxygen in a reaction catalysed by light. The intensity 
and wavelength of light as well as the amount of oxygen available influences 
the rate of degradation. Vitamin E is particularly sensitive to wavelengths 
between 285 nm and 305 nm24.  
 
Vitamin E seems to be relatively stable in admixtures especially when 
protected from light11–13,25. A study by Allwood and Martin12 investigated the 
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effect of light exposure on PN admixtures in multi-layered bags. They found 
that if oxygen was prevented from permeating into the bag, exposure to 
sunlight did not significantly reduce the concentration of vitamin E in the 
admixture. Additionally, in the presence of ascorbic acid, vitamin E oxidization 
is decreased as these two vitamins compete for oxygen12.  
 
Guidetti et al.21 also investigated the impact of lipid emulsion composition on 
tocopherol degradation. Like retinol, this study found that the recovery of both 
of the vitamin E isomers examined, α-tocopherol and γ-tocopherol, were 
significantly increased in AIO bags containing soybean-medium chain 
triacylglycerol oil-based emulsion when compared to soybean oil-based 
emulsions and olive/soybean oil-based emulsions. 
 
It is important to note that vitamin E is commonly presented as a mixture of 
eight tocopherol isomers and the stability profiles have not been determined 
for each of the isomers. The introduction of increased levels of tocopherol in 
an attempt to protect fish oils found in some PN from oxidation, necessitates a 
thorough understanding of tocopherol isomer stability profiles26. 
 
Vitamin K1 
 
Phylloquinone (vitamin K1) is a naturally occurring compound synthesized in 
plants. As it develops naturally in lipid emulsions some emulsions have higher 
concentrations than others27, so patients may receive different amounts. 
However, reports of the impact of phylloquinone levels on neonates suggest 
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that symptoms associated with increased levels (e.g. constipation and pain) 
are non-serious and self limiting28. 
 
Phylloquinone is sensitive to sunlight but is considered stable in PN mixtures 
in the presence and absence of lipid emulsions, supporting the theory that 
lipid emulsions have little, if any, protective influence on light sensitive 
vitamins. It has been reported that the concentration of phylloquinone can 
decrease by 50% following 3 hours in strong sunlight13. Another study has 
shown degradation of 5.9-8.5% over 4.5 hours in artificial daylight29. 
 
Water Soluble Vitamins 
Ascorbic acid 
 
Vitamin C is one of the most reactive vitamins added to PN admixtures. In the 
body it is a strong antioxidant that quenches reactive oxygen and nitrogen 
species30. When stored outside of the body, ascorbic acid acts in a similar 
way, reacting readily with oxygen. As shown in figure 1., ascorbic acid in the 
presence of oxygen is initially converted, by way of a reversible reaction, to an 
equally biologically active compound called dehydroascorbic acid. Hydrolysis 
of dehydroascorbic acid produces 2,3-diketo-gulonic acid, which is thought to 
be biologically inactive. Further oxidation of this intermediate produces 
threonic acid and oxalic acid. The degradation of ascorbic acid is directly 
linked to the amount of oxygen present in the medium31. Exclusion of free 
oxygen from the PN admixture limits the initial conversion of ascorbic acid to 
dehydroascorbic acid, thereby minimizing the resultant cascade32. Oxygen in 
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PN bags can originate from permeation of air through the bag wall during 
storage, residual headspace formed following filling and sealing and from 
dissolved air in injections of additives and infusions. The use of multilayered 
AIO bags has significantly reduced the amount of oxygen able to diffuse into 
the bags, thereby improving ascorbic acid stability8. However, this 
development has not eliminated the problem completely as oxygen 
transferred into the bag during filling cannot diffuse out of the bag and 
therefore remains in contact with the vitamin. 
 
Additives to PN not only accommodate the transfer of oxygen to the medium, 
but also can directly influence ascorbic acid degradation. Copper, and to a 
lesser extent manganese, zinc and ferric ions, catalyse the oxidation of 
ascorbic acid to dehydroascorbic acid32. This theory has recently been 
supported by an extensive study conducted by Ferreyra et al.33 who found 
significant degradation of ascorbic acid following the addition of nine trace 
elements to two-in-one (TIO) PN bags when compared to bags with no trace 
element additions. With copper, vitamin C is oxidized causing the concomitant 
reduction of copper from the cupric (II) to the cuprous (I) form. As a result of 
this, the cascade and the eventual production of threonic acid and oxalic acid 
speeds up. This reaction is enhanced by the introduction of such ions present 
as trace contaminants in PN components, resulting in higher concentration of 
copper available to catalyse the degradation of ascorbic acid34. Allwood35 
investigated compatibility and stability in 3 Litre bags and found that the amino 
acid cysteine inhibits the catalytic effect of copper. Therefore, inclusion of 
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cysteine in amino acid solutions may be beneficial in slowing the degradation 
of ascorbic acid. 
 
Physical conditions such as temperature and pH can also influence 
degradation of ascorbic acid in PN: at higher temperatures ascorbic acid 
degradation is increased36,37 and pH values above 4.0 make ascorbic acid 
more susceptible to oxidation30.  
 
The products of ascorbic acid degradation, oxalic acid and threonic acid, may 
compromise the stability of the emulsion by increasing the acidity. pHs below 
5 can destabilize the PN emulsions38. In addition, oxalic acid interacts with 
free calcium to produce calcium oxalate precipitate6. The impact of calcium 
oxalate formation in adults is unresolved but it is known to be hazardous to 
neonates31. Further investigation into the additional risks posed by oxalic acid 
and its precipitate is required.  
 
Thiamine 
 
In the past, thiamine in PN was degraded mainly by means of a reduction 
reaction. Sodium metabisulphite, a common antioxidant used in older 
generations of amino acid infusions, readily reacts with thiamine in solution8. 
This reaction involves the cleavage of thiamine molecules by sulphite into 
pyrimidine and thiazole. The stability of thiamine was directly linked to the 
concentration of sodium metabisulphite. Sodium metabisulphite is no longer 
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routinely used, with no amino acid solutions available in the UK containing it. 
Removal of this antioxidant has increased the stability of thiamine39.  
 
 
Riboflavin 
 
Riboflavin has long been thought to degrade when it is exposed to daylight. In 
the presence of light and oxygen, riboflavin is irreversibly converted to 
luminoflavin and luminochromo, amongst other compounds6. A recent study 
by Ferguson et al.15 found significant degradation (in excess of 10%) of 
riboflavin when exposed to cool and warm white artificial light over a period of 
24 hours. Significant degradation was also observed in a study by Mirkovic et 
al.40 following 12 hours of exposure of riboflavin to daylight. In contrast, 
studies by Dahl et al.11 and much more recently by Ribeiro et al.6 have shown 
no significant losses when stored at 25°C for 3 days and very little riboflavin 
loss when stored over a period of up to four days with and without light 
protection. However, the nature of the room illumination is not stated in any of 
these studies, so its influence is not quantifiable.  
 
One of riboflavin’s more undesirable properties is that it can act as a 
photochemical sensitizer41. As shown in figure 2., when riboflavin is in an 
excited state it can react directly with substrates or aid in the production of 
reactive oxygen species. Production of such reactive species may in turn, 
cause the oxidation of other PN constituents. Investigations into the effects of 
this process on various components of PN are ongoing42–44. 
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Pyridoxine 
 
Pyridoxine is known to be light sensitive, although, there is limited information 
available on its stability in admixtures. It has been reported to be stable in PN 
admixtures for up to 96 hours at 2-8°C in darkness11. Chen et al.45 reported 
an 86% loss of pyridoxine occurring in 8 hours of direct sunlight. A more 
recent study by Ribeiro et al.6, found that pyridoxine was stable for 3 days 
when stored between 4°C and 25°C with and without photo-protection. Again, 
the illumination of the room in which the samples were stored is not stated 
therefore it is difficult to ascertain the extent of its influence on degradation.  
 
Juhasz et al.46 examined the thermal decomposition of pyridoxine. In this 
experiment, they calculated the amount of time it takes to reach 90% 
pyridoxine recovery at 25°C to be 1.7x10-2 years (approximately 6.2 days). 
This experiment was conducted using a pure sample of pyridoxine and may 
not correspond to pyridoxine degradation in parenteral nutrition. 
 
Folic acid 
 
There are very few studies investigating the degradation of folic acid. The 
main source of instability arises from changes in pH. Folic acid injections are 
usually formulated at a pH in excess of 8.0 because the vitamin is prone to 
precipitation at lower pHs47. One investigation examined the effect of pH on 
folic acid precipitation and found that if the pH remains above 5.0, folic acid 
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remains in solution48. As PN usually has a pH of between 5.0-6.0, folic acid 
should not precipitate. 
 
There has been a suggestion by Lee et al.49 that adsorption of folic acid onto 
polyvinylchloride (PVC) infusion bags may occur and was responsible for a 
33% loss seen after 42 days of storage. However, later studies have found 
the vitamin to be compatible with PN bags11,48.  
 
Nicotinamide, Pantothenic acid, Biotin and Cyanocobalamin 
 
There is very limited information available on the stability of cyanocobalamin, 
pantothenic acid, biotin and nicotinamide in PN. Dahl et al.11 report that all 
four are stable in PN admixtures when stored for 96 hours. However, as no 
further studies have been reported, the stability of these water-soluble 
vitamins requires further investigation. 
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Conclusion 
 
The inclusion of vitamins in PN provides a number of formulation issues. 
Ascorbic acid is the most unstable vitamin added to PN and is degraded by 
oxygen into a number of different products including oxalic acid. There is 
some concern over the formation of oxalic acid, which may form a calcium 
oxalate precipitate. Further investigation into its impact is required.  
Photodegradation is a problem encountered with vitamins such as retinol and 
can cause significant losses. In addition, the impact of light on degradation in 
giving sets is an important consideration as the surface area of PN in contact 
with light is vastly increased. 
The role of riboflavin as a photochemical sensitizer is being explored.  
Its ability to form reactive oxygen species may have a significant impact on 
the stability of PN as a whole. 
Little is known about the stability of vitamins such as nicotinamide, 
cyanocoabalamin, biotin and pantothenic acid in PN. Clearly this needs some 
further investigation.  
Trace elements can also cause a number of problems during compounding 
and administration. A recent paper by Hardy et al.34, is an excellent review of 
the current literature available on trace elements. 
 
Many of the degradation processes of vitamins in PN admixtures can be 
reduced or prevented by controlling physical conditions. Light exposure can 
cause degradation of a number of water and fat-soluble vitamins, most 
notably riboflavin and retinol. Use of light protection on bags and 
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administration sets can reduce vitamin loss significantly. Degradation can be 
further reduced in administration sets through shortening the lines to the 
patient. This would decrease degradation caused by light sources and also 
help to decrease vitamin sorption onto the tubing10. The light protective effects 
of lipids on vitamins is a contentious issue that needs further investigation, 
nevertheless, the use of lipid may provide added protection for light sensitive 
vitamins. Oxygen is another problematic physical condition that is the cause 
of substantial vitamin degradation, with ascorbic acid being the worst affected. 
Use of multi-layered bags and removal of excess air after filling reduces 
degradation rates even in the presence of trace elements. The use of cysteine 
may also help inactivate copper catalysis of ascorbic acid oxidation to its 
degradation product dehydroascorbic acid. 
 
This review illustrates the importance of vitamin stability in parenteral nutrition. 
Maintaining vitamin stability will ensure that patients receive the correct doses 
and prevent the production of potentially harmful degradation products. 
Furthermore, it shows that there is still plenty of research to be done on 
vitamin stability in parenteral nutrition admixtures. 
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Figure 1. The ascorbic acid degradation cascade adapted from Allwood 
and Kearney4. 
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Figure 2. A flow diagram illustrating riboflavin as a photosensitizer. 
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Table 1. Vitamin Reference Nutrient Intake (RNI) values for healthy males 
and females aged between 19-50 years adapted from Department of 
Health reference values for Food Energy and Nutrients for the United 
Kingdom (41): 
 
Vitamin Males 19-50 years Females 19-50 years 
Vitamin A 700 μg/day 600 μg/day 
Vitamin D - - 
Vitamin E Above 4 mg/day Above 3 mg/day 
Vitamin K 1 μg/kg/day 1 μg/kg/day 
Ascorbic Acid 40 mg/day 40 mg/day 
Thiamine 1 mg/day 0.8 mg/day 
Riboflavin 1.3 mg/day 1.1 mg/day 
Niacin 17 mg/day 13 mg/day 
Pantothenic acid 3-7 mg/day 3-7 mg/day 
Pyridoxine 1.4 mg/day 1.2 mg/day 
Biotin 10-200 μg/day 10-200 μg/day 
Folate 200 μg/day 200 μg/day 
Cyanocobalamin 1.5 μg/day 1.5 μg/day 
 
N.B. Niacin describes the total amount of nicotinic acid and nicotinamide in 
the diet. 
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Table 2. Quick reference of known physical vitamin sensitivities: 
Vitamin Light Oxygen pH Temperature 
Vitamin A 
฀ 
   
Vitamin D 
    
Vitamin E 
฀ ฀ 
  
Vitamin K 
฀ 
   
Ascorbic acid 
 ฀ ฀ ฀ 
Thiamine 
    
Riboflavin 
฀ 
   
Nicotinamide 
    
Pantothenic 
Acid 
    
Pyridoxine 
฀ 
   
Biotin 
    
Folic Acid 
  
฀ 
 
Cyanocobalamin 
    
 
 
